Steven G Deeks Selected Research

Psoriasis (Pustulosis Palmaris et Plantaris)

2/2017	Psoriasis risk SNPs and their association with HIV-1 control.
2/2012	Psoriasis patients are enriched for genetic variants that protect against HIV-1 disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Steven G Deeks Research Topics

Disease

91	HIV Infections (HIV Infection) 05/2024 - 06/2002
78	Infections 03/2024 - 08/2003
49	Viremia 12/2023 - 01/2002
41	Inflammation (Inflammations) 10/2023 - 12/2006
33	Acquired Immunodeficiency Syndrome (AIDS) 01/2024 - 01/2007
27	COVID-19 04/2024 - 01/2021
16	Disease Progression 01/2020 - 12/2003
10	Post-Acute COVID-19 Syndrome 01/2024 - 01/2022
10	Neoplasms (Cancer) 01/2023 - 09/2012
8	Atherosclerosis 01/2020 - 06/2009
7	Persistent Infection 01/2022 - 06/2006
7	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 03/2011
5	Virus Diseases (Viral Diseases) 10/2023 - 12/2010
4	Latent Infection 10/2022 - 01/2016
4	Hypertension (High Blood Pressure) 10/2020 - 04/2004
4	Lymphoma (Lymphomas) 01/2018 - 08/2013
3	Tuberculosis (Tuberculoses) 01/2024 - 09/2011
3	Carotid Artery Diseases 01/2020 - 02/2011
3	Fibrosis (Cirrhosis) 01/2017 - 10/2011
3	Coinfection 12/2016 - 09/2009
3	Chronic Disease (Chronic Diseases) 11/2013 - 07/2010
2	Dysbiosis 05/2024 - 07/2013
2	Latent Tuberculosis 01/2024 - 04/2007
2	Asymptomatic Infections 08/2023 - 10/2022
2	Fatigue 01/2023 - 07/2022
2	Communicable Diseases (Infectious Diseases) 12/2021 - 01/2016
2	Fever (Fevers) 07/2021 - 03/2021
2	Cough 07/2021 - 03/2021
2	Arteritis 01/2021 - 01/2017
2	Myocardial Infarction 01/2019 - 09/2009
2	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2017 - 02/2012
2	Pulmonary Arterial Hypertension 01/2016 - 02/2014

Drug/Important Bio-Agent (IBA)

58	RNA (Ribonucleic Acid)IBA 12/2023 - 02/2002
17	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 03/2011
17	Biomarkers (Surrogate Marker)IBA 01/2023 - 04/2010
13	AntigensIBA 04/2024 - 03/2004
12	CytokinesIBA 01/2023 - 11/2005
11	Proteins (Proteins, Gene)FDA Link 10/2023 - 12/2010
11	Interleukin-6 (Interleukin 6)IBA 01/2023 - 04/2012
10	AntibodiesIBA 11/2023 - 01/2014
9	Antiviral Agents (Antivirals)IBA 11/2023 - 06/2002
9	fibrin fragment D (D-dimer)IBA 12/2016 - 04/2012
8	Lipopolysaccharide ReceptorsIBA 12/2016 - 03/2011
7	Tryptophan (L-Tryptophan)FDA Link 01/2024 - 02/2013
7	Immunoglobulin G (IgG)IBA 01/2023 - 06/2012
7	Peptides (Polypeptides)IBA 10/2021 - 12/2010
6	InterferonsIBA 11/2023 - 04/2007
6	C-Reactive ProteinIBA 01/2021 - 04/2012
5	KynurenineIBA 01/2024 - 07/2013
5	HLA-B Antigens (HLA-B)IBA 01/2024 - 06/2007
5	HLA Antigens (Human Leukocyte Antigens)IBA 01/2024 - 12/2010
5	VaccinesIBA 01/2022 - 01/2011
5	Messenger RNA (mRNA)IBA 01/2022 - 01/2014
5	Protease Inhibitors (Protease Inhibitor)IBA 02/2017 - 08/2003
5	HLA-DR Antigens (HLA-DR)IBA 04/2011 - 03/2006
4	COVID-19 VaccinesIBA 11/2023 - 08/2021
4	Broadly Neutralizing AntibodiesIBA 11/2023 - 01/2019
4	Clostridium perfringens epsilon-toxinIBA 03/2023 - 06/2022
3	EpitopesIBA 01/2024 - 01/2020
3	Neutralizing AntibodiesIBA 11/2023 - 06/2006
3	AutoantibodiesIBA 11/2023 - 01/2023
3	Interleukin-17 (Interleukin 17)IBA 01/2023 - 05/2010
3	Viral ProteinsIBA 01/2020 - 08/2017
3	Interferon-gamma (Interferon, gamma)IBA 12/2017 - 09/2009
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2017 - 07/2014
3	Immunoglobulins (Immunoglobulin)IBA 01/2017 - 07/2014
3	LipopolysaccharidesIBA 11/2014 - 01/2008
3	Tenofovir (Viread)FDA Link 06/2014 - 06/2011
3	HLA-C Antigens (HLA-C)IBA 12/2013 - 12/2009
3	abacavir (Ziagen)FDA Link 11/2012 - 09/2009
2	vesatolimodIBA 05/2024 - 01/2021
2	nirmatrelvirIBA 01/2024 - 01/2022
2	Interferon Type IIBA 10/2023 - 01/2017
2	ProteomeIBA 02/2023 - 01/2023
2	2- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA 02/2023 - 01/2023
2	AutoantigensIBA 02/2023 - 01/2023
2	Nuclear Antigens (Extractable Nuclear Antigens)IBA 01/2023 - 07/2022
2	Nucleic AcidsIBA 10/2022 - 03/2021
2	Oxygen (Dioxygen)IBA 07/2021 - 03/2021
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 01/2020
2	LDL Lipoproteins (beta Lipoproteins)IBA 10/2020 - 11/2014
2	Indicators and Reagents (Reagents)IBA 02/2020 - 03/2012
2	HLA-B57 antigenIBA 01/2020 - 11/2017
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 08/2015
2	CCR5 Receptors (CCR5 Receptor)IBA 01/2019 - 08/2015
2	Brentuximab VedotinIBA 12/2018 - 01/2018
2	ChemokinesIBA 01/2018 - 01/2016
2	PerforinIBA 01/2018 - 03/2006
2	HIV AntibodiesIBA 01/2018 - 01/2017
2	LigandsIBA 01/2017 - 02/2012
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2017 - 04/2015
2	Chemokine ReceptorsIBA 01/2016 - 04/2012
2	Disulfiram (Antabuse)FDA Link 12/2015 - 03/2014

Therapy/Procedure

84	Therapeutics 10/2023 - 01/2002
35	Art Therapy 05/2024 - 11/2005
18	Highly Active Antiretroviral Therapy (HAART) 03/2023 - 06/2002
3	Aftercare (After-Treatment) 01/2024 - 01/2004
3	Immunotherapy 01/2024 - 01/2020
2	Duration of Therapy 01/2020 - 11/2005
2	Secondary Prevention 02/2016 - 09/2009